Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001127602-21-018315
Filing Date
2021-05-28
Accepted
2021-05-28 16:14:44
Documents
2
Period of Report
2021-05-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form3.html 3  
1 PRIMARY DOCUMENT form3.xml 3 1517
2 POWER OF ATTORNEY (PUBLIC): POA MAY 2021 doc1.txt EX-24 5581
  Complete submission text file 0001127602-21-018315.txt   8668
Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000
Business Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 L2 00000 00-353-1-772-8000
Alkermes plc. (Issuer) CIK: 0001520262 (see all company filings)

EIN.: 981007018 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O AMNEAL PHARMACEUTICALS LLC 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address
Alva Emily Peterson (Reporting) CIK: 0001738422 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35299 | Film No.: 21980346